# Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

> **NCT04243629** · NA · UNKNOWN · sponsor: **McGill University** · enrollment: 26 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Type 1 Diabetes
- Postprandial Hyperglycemia

## Interventions

- **DRUG:** Rapid-Acting Insulin
- **DRUG:** Placebo
- **DRUG:** Pramlintide Acetate
- **DEVICE:** Artificial Pancreas

## Key facts

- **NCT ID:** NCT04243629
- **Lead sponsor:** McGill University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-12
- **Primary completion:** 2024-04
- **Final completion:** 2024-04
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2023-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04243629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04243629, "Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04243629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*